Clinical Trials Browser

Phase 3 × icotinib × Thoracic × Clear all

NCT01996098 2024-09-05

ICTAN

Phase 3 Terminated

Lung Neoplasms

NCT06041776 2023-09-22

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT02448797 2021-07-20

EVIDENCE

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04797806 2021-03-15

SAINT

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04058704 2019-08-15

SMART

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03992885 2019-06-20

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

Phase 3 Unknown

Non-squamous Non-small Cell Lung Cancer

NCT01724801 2017-03-01

BRAIN

Phase 3 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02883543 2016-08-30

First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02486354 2015-07-01

Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

NCT01040780 2014-02-14

ICOGEN

Phase 3 Completed

399 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung